Published in Blood Weekly, April 13th, 2006
Total 2005 net product sales for Ventavis, which was launched in March 2005, were $23.9 million.
"[Last year] was a tremendous year for CoTherix as we successfully transitioned into a commercial organization with the launch of Ventavis for pulmonary arterial hypertension. We've established critical talent in sales, marketing, and reimbursement and intend to leverage this commercial...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.